Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.1067 per EA under NDC 00904666245. Its NADAC has been published 412 times since Aug 8, 2018.
Strength
30 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904666245
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA091269On Market Since
10/15/2010
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 412 times since Aug 8, 2018, and over the history we have for it it has declined 50.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1067 per EA |
|---|---|
| All-time high | $0.2139 (Aug 15, 2018) |
| All-time low | $0.0754 (Nov 20, 2024) |
| 52-week high | $0.1104 |
| 52-week low | $0.1049 |
| Median price | $0.1189 |
| Average price | $0.1347 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 412 |
| Tracking since | Aug 8, 2018 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.1067 per EA (NDC 00904666245), effective Jun 24, 2026.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 50.1%. It has been tracked across 412 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since Aug 8, 2018, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.0754 (Nov 20, 2024) to a high of $0.2139 (Aug 15, 2018), with a median of $0.1189 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as LANSOPRAZOLE DR 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 00904666245) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification